A 3D primary human cell-based in vitro model of non-alcoholic steatohepatitis for efficacy testing of clinical drug candidates

FFAs and LPS together enhance the disease phenotype of the in vitro

Human‐based systems: Mechanistic NASH modelling just around the corner?

Research articles Scientific Reports

3D In Vitro MASH Model for Preventive Screening

Cancers, Free Full-Text

PDF] Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype.

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH). - Abstract - Europe PMC

Human‐based systems: Mechanistic NASH modelling just around the corner?

IJMS, Free Full-Text

Preparation scheme for the isolation of primary liver cells. Liver cell